# GLP-1 Digest: Latest Research and Clinical Updates April 16, > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/glp-1-receptor-agonists-liver-benefits-april-16/ > **Published:** 2026-04-16T11:46:52-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:01:25-04:00 > **Clinical Summary:** Explore new evidence on GLP-1 receptor agonists liver benefits, weight loss, and diabetes prevention in this April 16 update from CED Clinic. --- #### Clinical Takeaway This issue examines a convergence of compelling evidence across metabolic medicine, with new research strengthening the case for GLP-1 receptor agonists in liver disease management, weight loss optimization, and diabetes prevention. Genetic predictors of GLP-1 treatment response, the evolving role of metformin in insulin resistance, and updated obesity and diabetes outcome data round out a clinically rich collection of findings with direct implications for practice. GLP-1 Digest | April 16, 2026 This issue examines a convergence of compelling evidence across metabolic medicine, with new research strengthening the case for GLP-1 receptor agonists in liver disease management, weight loss optimization, and diabetes prevention. Genetic predictors of GLP-1 treatment response, the evolving role of metformin in insulin resistance, and updated obesity and diabetes outcome data round out a clinically rich collection of findings with direct implications for practice. ### GLP-1 News - [GLP-1 Receptor Agonist Benefits for Liver Health: New Evidence](https://cedclinic.com/glp-1-receptor-agonist-shows-liver-benefits-new-research/)GLP-1 receptor agonists may improve [liver health](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/) outcomes, though prescribers should interpret findings carefully given the observational study design and moderate evidence level. - [GLP-1 Receptor Agonist Shows Liver Benefits in New Research](https://cedclinic.com/glp-1-receptor-agonist-benefits-liver-health/)GLP-1 receptor agonists may provide hepatic benefits beyond glycemic control, relevant for prescribers managing metabolic liver disease in patients on semaglutide therapy. - [Metformin & Insulin Resistance: Diabetes Prevention Evidence](https://cedclinic.com/metformin-diabetes-prevention-insulin-resistance-evidence/)Metformin demonstrates moderate clinical relevance for GLP-1 prescribers by providing evidence of diabetes prevention in adults with obesity and prediabetes through insulin resistance reduction. - [GLP-1 Drugs: Obesity & Diabetes Treatment Evidence 2026](https://cedclinic.com/glp-1-cannabis-use-disorder-bmj-cohort-study/)GLP-1 receptor agonists show moderate clinical relevance for obesity and diabetes treatment, requiring careful interpretation by prescribers when applying evidence to practice. ### GLP-1 Studies - [GLP-1 Weight Loss Efficacy: Genetic Links Found](https://cedclinic.com/glp-1-receptor-agonist-efficacy-linked-to-genetics/)Summary Genome-wide association studies identified genetic factors that may predict individual variation in weight loss response to GLP-1 medications like semaglutide. - [GLP-1 Weight Loss Results Linked to Genetic Predictors](https://cedclinic.com/pharmacogenomic-stratification-glp-1-response-weight-loss/)Clinical Summary Genetic factors may predict individual weight loss responses to GLP-1 medications, suggesting personalized treatment approaches could optimize outcomes for patients. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Nationwide GLP-1 Care Looking for thoughtful, physician-led GLP-1 guidance? CED Clinic offers GLP-1 and metabolic guidance across the United States, including evaluation, prescribing support, side-effect management, and longer-term follow-up for people seeking careful, personalized care. [Learn More](https://cedclinic.com/metabolic/) [Book Now](https://book.squareup.com/appointments/kn3vehwoiz6to6/location/DPV0VF8Y74WA7/services) RELATED READING AT CED CLINIC Continue exploring the evidence [GLP-1 Digest: Latest Research and Clinical Updates April 17,](https://cedclinic.com/glp-1-receptor-agonist-discontinuation-evidence-overview/) Review the latest evidence on GLP-1 receptor agonist discontinuation and clinical implications from the April 17 update. [Read More](https://cedclinic.com/glp-1-receptor-agonist-discontinuation-evidence-overview/) [GLP-1 Digest: Latest Research and Clinical Updates April 23,](https://cedclinic.com/glp-1-digest-april-23-clinical-updates/) Stay informed with the April 23 GLP-1 Digest covering new research and [clinical updates](https://cedclinic.com/medicinal-cannabis-clinical-updates-2026-friday-roundup/) in metabolic medicine. [Explore Now](https://cedclinic.com/glp-1-digest-april-23-clinical-updates/) [GLP-1 Receptor Agonists: Clinical Evidence Beyond Weight](https://cedclinic.com/glp-1-receptor-agonists-metabolic-benefits/) Discover [clinical evidence](https://cedclinic.com/academic-partnerships-cannabis-research/) on GLP-1 receptor agonists benefits beyond weight loss, including liver and metabolic health. [Learn More](https://cedclinic.com/glp-1-receptor-agonists-metabolic-benefits/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=GLP-1%20Digest%3A%20Latest%20Research%20and%20Clinical%20Updates%20April%2016%2C&url=https%3A%2F%2Fcedclinic.com%2Fglp-1-receptor-agonists-liver-benefits-april-16%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fglp-1-receptor-agonists-liver-benefits-april-16%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=GLP-1%20Digest%3A%20Latest%20Research%20and%20Clinical%20Updates%20April%2016%2C%20https%3A%2F%2Fcedclinic.com%2Fglp-1-receptor-agonists-liver-benefits-april-16%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).